Insiders / Nagendran Sukumar

Nagendran Sukumar

CIK 1665124personinsider
Companies
1
First seen
Jan 14, 2026
Last activity
Jan 27, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Taysha Gene Therapies, Inc. · TSHAExecutive1,317,3891,433,4399

All securities held

2 positions · latest reported per filing
CompanySecuritySharesAs of
Taysha Gene Therapies, Inc.Common Stock1,317,389Jan 26, 2026
Taysha Gene Therapies, Inc.Employee Stock Option (right to buy)Derivative274,000Jan 12, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Jan 12, 2026SellTSHA
Taysha Gene Therapies, Inc.
Common Stock
$942.0K-200K
-16.58%
1,006,439
0.31% of shares
medium
Jan 23, 2026SellTSHA
Taysha Gene Therapies, Inc.
Common Stock
$423.4K-89K
-6.22%
1,344,307
0.41% of shares
medium
Jan 12, 2026ExerciseTSHA
Taysha Gene Therapies, Inc.
Common Stock
$151.6K+89K
+7.93%
1,206,439
0.37% of shares
low
Jan 26, 2026SellTSHA
Taysha Gene Therapies, Inc.
Common Stock
$124.1K-27K
-2.00%
1,317,389
0.40% of shares
medium
Jan 12, 2026ExerciseTSHA
Taysha Gene Therapies, Inc.
Common Stock
$77.8K+111K
+11.06%
1,117,763
0.34% of shares
low
Jan 12, 2026GrantTSHA
Taysha Gene Therapies, Inc.
Common Stock
$0+427K
+42.43%
1,433,439
0.44% of shares
low
Jan 12, 2026GrantTSHA
Taysha Gene Therapies, Inc.
Employee Stock Option (right to buy)
+274K
274,000
0.08% of shares
low
Jan 12, 2026ExerciseTSHA
Taysha Gene Therapies, Inc.
Employee Stock Option (right to buy)
-89K
-15.73%
474,941
0.15% of shares
low
Jan 12, 2026ExerciseTSHA
Taysha Gene Therapies, Inc.
Employee Stock Option (right to buy)
-111K
-49.99%
111,359
0.03% of shares
low